Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet-Reference-Cited by-同舟云学术

Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet

Published:2009-11 Issue:11 Volume:30 Page:1505-1512
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Guo Hong-xia,Liu Dai-hua,Ma Ying,Liu Jin-feng,Wang Ying,Du Zhi-yan,Wang Xin,Shen Jing-kang,Peng Hong-li

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps2009150.pdf

Reference37 articles.

1. Boden G . Obesity and free fatty acids. Endocrinol Metab Clin North Am 2008; 37: 635–46.

2. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G . Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 2004; 5: 27–42.

3. Akbar DH, Kawther AH . Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know. Med Sci Monit 2006; 12: RA23–RA26.

4. Clark JM, Diehl AM . Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003; 289: 3000–4.

5. Wieckowska A, McCullough AJ, Feldstein AE . Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007; 46: 582–9.

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baicalin suppresses macrophage JNK-mediated adipose tissue inflammation to mitigate insulin resistance in obesity;Journal of Ethnopharmacology;2024-10

2. Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics;Biology;2024-07-23

3. An optimal combination of four active components in Huangqin decoction for the synergistic sensitization of irinotecan against colorectal cancer;Chinese Medicine;2024-07-02

4. Molecular targets and therapeutic potential of baicalein: a review;Drug Target Insights;2024-06-06

5. Improved Bioavailability and Hepatoprotective Activity of Baicalein Via a Self-assembled Solutol HS15 Micelles System;Current Drug Delivery;2024-03